Target intelligence / Profile preview

Unintended human messenger RNAs with partial complementarity to short hairpin RNA (shRNA) seed regions

Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Unintended human messenger RNAs (mRNAs) with partial complementarity to short hairpin RNA (shRNA) seed regions represent a major class of off-target effects in RNA interference (RNAi) technology. These mRNAs are inadvertently silenced when the seed region, comprising nucleotides 2 through 8 of the shRNA-derived guide strand, binds to their 3' untranslated regions (UTRs) with partial complementarity (Jackson et al., 2003; Birmingham et al., 2006). This interaction mimics the natural regulatory mechanism of microRNAs (miRNAs), resulting in unintended translational repression or mRNA degradation. Such off-target silencing can lead to significant cellular toxicity, altered experimental phenotypes, and safety risks in clinical applications, most notably hepatotoxicity (Grimm et al., 2006). In the context of drug development, these interactions are a primary hurdle, necessitating rigorous bioinformatic screening and chemical modifications to the RNA backbone to enhance specificity. Furthermore, high levels of shRNA expression can saturate the endogenous RNAi machinery, such as Exportin-5 and the RNA-induced silencing complex (RISC), which compounds the toxic effects (Grimm et al., 2006). Consequently, identifying and avoiding these unintended mRNA interactions is essential for the design of safe and effective RNAi-based therapeutics (Setten et al., 2019). This phenomenon highlights the importance of sequence specificity beyond the intended target site in the development of nucleic acid-based medicines.

Other names
Seed-mediated off-targetsmiRNA-like off-target effectsRNAi off-targetsshRNA-induced off-target transcriptsSeed-matched off-target mRNAs
02

Mechanism of action

Seed-mediated RNA interference (RNAi) involving the binding of the shRNA/siRNA guide strand seed region (nucleotides 2-8) to partially complementary sequences in the 3' UTR of unintended mRNAs, leading to miRNA-like gene silencing (Jackson et al., 2003; Birmingham et al., 2006).

03

Biological functions

Gene expression regulationTranslationRNA interference
04

Disease associations

ToxicityOff-target effectsLiver injury
05

Safety considerations

HepatotoxicityNeurotoxicitySaturation of RNAi machinery (Exportin-5/RISC)Unintended gene silencingImmune activation (TLR7/8)
06

Interacting drugs

Patisiran

6 more in the full profile.

07

Biomarkers

Transcriptome profilingRNA-seqMicroarray analysisALT/AST levelsReporter gene assays

Beyond the preview

Go deeper on Unintended human messenger RNAs with partial complementarity to short hairpin RNA (shRNA) seed regions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unintended human messenger RNAs with partial complementarity to short hairpin RNA (shRNA) seed regions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call